johnson & johnson

Welcome to the 'johnson & johnson' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'johnson & johnson'.

Are you an expert about 'johnson & johnson'? Do you want to be the Technorati authority on 'johnson & johnson'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “johnson & johnson”

 

• Cook Medical Surgical Mesh Lawsuits Consolidated in 6th MDL in W.V.

  
  — Authority:
  A panel of federal judges has agreed to consolidate all Cook Medical surgical mesh lawsuits filed in U.S. District Courts throughout the country as part of a multidistrict litigation (MDL) in West Virginia, centralizing the litigation before the same judge who is presiding over five other MDLs established for ...
  4 days ago

• Johnson & Johnson Sells Remaining Stake in Elan (JNJ)

  
  Dividend Stocks - The Dividend Daily — Authority: 139
  Healthcare product company, Johnson & Johnson ( JNJ ) reported on Friday that it has sold 25.4 million shares of Elan Corp, ending its relationship with the Ireland based company. . In 2009, JNJ took a 18% stake in the biotechnology company for $1 billion to take over its development in bapineuzumab. ...
  4 days ago

• Johnson & Johnson (JNJ): Is This Healthcare Company a Strong Investment?

  
  — Authority:
  The slowdown in stock market has also adversely affected leading healthcare companies’ stocks. But many still think investing in healthcare giants such as Johnson & Johnson (NYSE : JNJ ) is the right move. Let’s take a closer look at this company and break down its main strong points, opportunities, and ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  Brandweek - TECHNOLOGY FINANCE — Authority: 134
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• The Philly Cream Cheese Agency Shift Took a While

  
  — Authority:
  Kraft Foods’ shift of creative responsibilities for Philadelphia Cream Cheese came after months of meetings between Kraft executives and new agency Roberts + Langer DDB, according to sources. The meetings began in the fall and culminated today with Kraft’s confirmation of the shift, which comes at the expense ...
  5 days ago

• Automakers Dominate Green Brands Ranking

  
  Environmental Leader — Authority: 543
  Toyota has retained the top spot on Interbrand’s 2013 Best Global Green Brands ranking for the third year running. Automotive brands account for four of the top five spots in this year’s ranking with innovation driving their success, according to the report, which evaluates and ranks companies on their ...
  5 days ago

• Undervalued Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Must Enter New Markets

  
  — Authority:
  Generic producers are often regarded as the safer players within BioPharma. They take existing drugs that have fallen off patents, tweak them a bit, and release a product into the market. R&D expenses are kept low, and business is relatively predictable. Similarly, medical device companies have lower risk ...
  5 days ago

• J&J’s Stelara Shows Progress In Arthritis Treatment and 2 Other Dow Movers to Watch

  
  — Authority:
  Johnson & Johnson ( NYSE:JNJ ): Current price $83.82 According to data being presented at a medical meeting in Europe, Johnson & Johnson’s Stelara exhibited significant improvement in signs and symptoms of psoriatic arthritis through 52 weeks of treatment in a late stage evaluation. The Phase III trial ...
  6 days ago

• Maggie Gyllenhaal Opens Up on Balancing Acting and Kids, How Ramona Handles Fans, and the Power of Band-Aids

  
  — Authority:
  With two little girls running around her Brooklyn home, Maggie Gyllenhaal is very familiar with the ubiquitous Johnson & Johnson First Aid Kit. The kit, which is celebrating its 125th anniversary this year, has come to the rescue of everyone from railroad workers (its original intended audience) to soccer moms ...
  6 days ago

• Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)

  
  — Authority:
  Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates.
  6 days ago

• Bellwether Trial for DePuy ASR Hip Implant Scheduled for October in N.J.

  
  — Authority:
  A “bellwether” trial has been scheduled to begin in October in New Jersey state court involving the recalled DePuy ASR hip implant . This will be at least the third DePuy ASR lawsuit to reach a jury in the country, but the first case in the state of New Jersey, where hundreds of similar complaints are pending. ...
  6 days ago

• The Cooper Companies, Inc. (COO), Valeant Pharmaceuticals Intl Inc (VRX): Tme to Buy This Defensive Growth Stock?

  
  — Authority:
  Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE: COO ) . In general, ophthalmology is an industry that can grow irrespective of the economy. Within this, The Cooper Companies, Inc. (NYSE:COO) has its own mix of earnings drivers ...
  6 days ago

• Mystery solved? Research blames ruptured plaque for stent related blood clots

  
  — Authority:
  South Korean scientists believe they may have solved what causes very late stent thrombosis (blood clots) after drug-eluting or bare-metal stent implants. And their solution opens up a door to treating long-term stent patients and helping to boost their survival rates.
  6 days ago

• Johnson & Johnson Drug Receives Positive Data in Trials (JNJ)

  
  Dividend Stocks - The Dividend Daily — Authority: 139
  According to data being presented at a medical meeting in Europe, Johnson & Johnson’s ( JNJ ) new drug to combat psoriatic arthritis, Stelara, has produced positive results in recent testing and trials. Through 52 weeks of treatment the drug has produced significant improvements in psoriatic ...
  6 days ago

Comments about johnson & johnson